Company: IPSC
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-110851
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
Item 1. Unaudited Consolidated Financial Statements.

CENTURY THERAPEUTICS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

​

​​​​​​​​​​September 30, 2025​December 31, 2024​​    (unaudited)    ​​Assets​​​​​​​​​​​​​​​Current assets​​​​​​​Cash and cash equivalents​$55,515​$ 58,441​Short-term investments​ 77,234​  130,851​Prepaid expenses and other current assets​ 4,960​  4,759​Total current assets​  137,709​  194,051​​​​​​​​​Property and equipment, net​ 53,715​  62,141​Operating lease right-of-use assets​​16,566​​ 28,706​Restricted cash​​2,314​​ 2,772​Long-term investments​  —​  30,818​Intangible assets​​ 34,200​​ 34,200​Security deposits and non-current assets​  213​  528​Total assets​$ 244,717​$ 353,216​​​​​​​​​Liabilities and stockholders’ equity​   ​   ​​​​​​​​​Current liabilities​ ​​   ​Accounts payable​$ 2,617​$ 3,075​Accrued expenses and other liabilities​  11,051​  17,461​Contingent consideration liability, short-term​​ 8,338​​ —​Deposit liability ​​ 20​​ 82​Deferred revenue, current​​ —​​ 109,164​Total current liabilities​  22,026​  129,782​​​​​​​​​Operating lease liability, long term​  41,185​  48,960​Contingent consideration liability, long-term​  784​  8,738​Deferred tax liability​  4,374​  4,374​​​​​​​​​Total liabilities​  68,369​  191,854​​​​​​​​​Commitments and contingencies (Note 8)​   ​   ​Stockholders' equity:​​​​​​​Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at September 30,